| 37768170 | Estimating the Burden of Influenza Hospitalizations Across Multiple Seasons Using Capture-Recapture. | J Infect Dis | 2024 |
| 36300969 | Drug use and severe outcomes among adults hospitalized with influenza, 2016-2019. | Influenza Other Respir Viruses | 2023 |
| 37662226 | SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis. | medRxiv | 2023 |
| 37769676 | Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010-19: a repeated cross-sectional study. | Lancet Microbe | 2023 |
| 35580849 | Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States. | Clin Infect Dis | 2023 |
| 35594564 | Comparison of Influenza and Coronavirus Disease 2019-Associated Hospitalizations Among Children Younger Than 18 Years Old in the United States: FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021). | Clin Infect Dis | 2023 |
| 37246146 | Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network. | Influenza Other Respir Viruses | 2023 |
| 37104244 | Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 37073852 | Traditional definition of healthcare-associated influenza underestimates cases associated with other healthcare exposures in a population-based surveillance system. | Infect Control Hosp Epidemiol | 2023 |
| 37132204 | Vaccination Status and Trends in Adult Coronavirus Disease 2019-Associated Hospitalizations by Race and Ethnicity: March 2020-August 2022. | Clin Infect Dis | 2023 |
| 36995184 | Codetections of Other Respiratory Viruses Among Children Hospitalized With COVID-19. | Pediatrics | 2023 |
| 36656786 | Early and Increased Influenza Activity Among Children - Tennessee, 2022-23 Influenza Season. | MMWR Morb Mortal Wkly Rep | 2023 |
| 36883903 | Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants. | J Infect Dis | 2023 |
| 36751004 | Risk of Acute Myocardial Infarction Among Patients With Laboratory-Confirmed Invasive Pneumococcal Disease: A Self-Controlled Case Series Study. | Clin Infect Dis | 2023 |
| 36694363 | Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter Study. | Clin Infect Dis | 2023 |
| 36875205 | Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 states, March 2020-April 2022. | Influenza Other Respir Viruses | 2023 |
| 36504336 | Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season. | Clin Infect Dis | 2023 |
| 36705269 | Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020-2022. | J Infect Dis | 2023 |
| 36701144 | Household Transmission of Influenza A Viruses in 2021-2022. | JAMA | 2023 |
| 36754516 | Acute Cardiac Events During COVID-19-Associated Hospitalizations. | J Am Coll Cardiol | 2023 |
| 36335639 | Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trial. | Eur J Heart Fail | 2023 |
| 36327388 | Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022. | Clin Infect Dis | 2023 |
| 34320171 | Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). | Clin Infect Dis | 2022 |
| 35512334 | SARS-CoV-2 Virus Dynamics in Recently Infected People-Data From a Household Transmission Study. | J Infect Dis | 2022 |
| 35442437 | Surveillance and Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Viral RNA, Antigen, Virus Isolation, and Self-Reported Symptoms in a Longitudinal Study With Daily Sampling. | Clin Infect Dis | 2022 |
| 35771731 | Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35438769 | Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in US Children Over 9 Seasons Following the 2009 H1N1 Pandemic. | Clin Infect Dis | 2022 |
| 35446827 | Hospitalizations of Children Aged 5-11 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35385875 | mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients. | J Infect Dis | 2022 |
| 36520656 | Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza - United States, 2021-22 Influenza Season. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36695662 | Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022. | Open Forum Infect Dis | 2022 |
| 36580424 | Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged â¿¥65 Years - IVY Network, 18 States, September 8-November 30, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36686630 | Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015-2019. | Open Forum Infect Dis | 2022 |
| 36074486 | COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022. | JAMA Intern Med | 2022 |
| 35970493 | Characteristics and treatment of hospitalized pregnant women with COVID-19. | Am J Obstet Gynecol MFM | 2022 |
| 36355612 | Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35925807 | Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged â¿¥18 years - United States, July 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36264830 | Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36220174 | Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study. | BMJ | 2022 |
| 36006864 | Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season. | MMWR Recomm Rep | 2022 |
| 35271561 | Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35085226 | Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 34935038 | Risk Factors for Severe COVID-19 in Children. | Pediatrics | 2022 |
| 35085218 | Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021. | MMWR Morb Mortal Wkly Rep | 2022 |
| 34932114 | Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021. | J Infect Dis | 2022 |
| 35298454 | The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged â¿¥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35264324 | Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. | BMJ | 2022 |
| 35051137 | Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35263382 | Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure-United States, 2015-2017. | PLoS One | 2022 |
| 35194642 | Household Transmission and Clinical Features of SARS-CoV-2 Infections. | Pediatrics | 2022 |